NCT05303259View on ClinicalTrials.gov

Effect of Bevacizumab on Asymptomatic Radiotherapy-induced Brain Injury

PHASE2RecruitingINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2025

Conditions
Brain Injuries
Interventions
DRUG

Bevacizumab

Bevacizumab 2.5mg/kg, q2w, 4 cycles.

Trial Locations (1)

510120

RECRUITING

Sun Yat-Sen Memorial Hospital, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER